Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Elborn

Showing results (81-90 of 325) with videos related to

Pageof 33
Sort By:
Journal of Global Antimicrobial Resistance|February 9, 2024
In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasisMichael M Tunney, J Stuart Elborn, Chloe S McLaughlin, et al.
The Journal of Dairy Research|October 9, 2002
Effect of high-temperature short-time (HTST) laboratory pasteurization on the survival of Burkholderia cepacia complex organisms in whole, low fat and skimmed milksJohn E Moore, B Cherie Millar, Thomas Buckley, et al.
Archives of Physical Medicine and Rehabilitation|August 3, 2011
Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trialKatherine A Lavery, Brenda O'Neill, Michael Parker, et al.
Journal of Microbiological Methods|February 7, 2002
Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosisJohn E Moore, Jiru Xu, Beverley C Millar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2016
Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapyJ Stuart Elborn, Jane Davies, Marcus A Mall, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 4, 2016
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infectionJ Stuart Elborn, Patrick A Flume, Fredric Cohen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2019
Speeding up access to new drugs for CF: Considerations for clinical trial design and deliveryJane C Davies, Pavel Drevinek, J Stuart Elborn, et al.
Respiration; International Review of Thoracic Diseases|June 9, 2005
Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus AcapellaJanet E Patterson, Judy M Bradley, Oonagh Hewitt, et al.
Chest|September 13, 2002
Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPDMartin G Kelly, Vanessa Brown, S Lorraine Martin, et al.
Pediatric Pulmonology|June 26, 2007
The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammationDamian G Downey, Simon Brockbank, S Lorraine Martin, et al.
Pageof 33

Showing results (81-90 of 325) with videos related to

Sort By:
Pageof 33
Journal of Global Antimicrobial Resistance|February 9, 2024
In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasisMichael M Tunney, J Stuart Elborn, Chloe S McLaughlin, et al.
The Journal of Dairy Research|October 9, 2002
Effect of high-temperature short-time (HTST) laboratory pasteurization on the survival of Burkholderia cepacia complex organisms in whole, low fat and skimmed milksJohn E Moore, B Cherie Millar, Thomas Buckley, et al.
Archives of Physical Medicine and Rehabilitation|August 3, 2011
Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trialKatherine A Lavery, Brenda O'Neill, Michael Parker, et al.
Journal of Microbiological Methods|February 7, 2002
Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosisJohn E Moore, Jiru Xu, Beverley C Millar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 18, 2016
Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapyJ Stuart Elborn, Jane Davies, Marcus A Mall, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 4, 2016
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infectionJ Stuart Elborn, Patrick A Flume, Fredric Cohen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2019
Speeding up access to new drugs for CF: Considerations for clinical trial design and deliveryJane C Davies, Pavel Drevinek, J Stuart Elborn, et al.
Respiration; International Review of Thoracic Diseases|June 9, 2005
Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus AcapellaJanet E Patterson, Judy M Bradley, Oonagh Hewitt, et al.
Chest|September 13, 2002
Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPDMartin G Kelly, Vanessa Brown, S Lorraine Martin, et al.
Pediatric Pulmonology|June 26, 2007
The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammationDamian G Downey, Simon Brockbank, S Lorraine Martin, et al.
Pageof 33